Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending September 10, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending September 10, 2023

by Jonathan Hodson-Walker | Sep 15, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Apollo Therapeutics: The company raised $226.5 million of Series C venture funding in a deal led by Patient Square Capital on September 6, 2023. Rock Springs Capital and M&G also...
Healthcare Private Placement and M&A Transactions Review Week Ending September 3, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending September 3, 2023

by Jonathan Hodson-Walker | Sep 7, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Rakuten Medical: The company raised $180 million of venture funding from undisclosed investors on September 1, 2023. The company is a developer of precision-targeted cancer therapies designed...
Healthcare Private Placement and M&A Transactions Review Week Ending August 27, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending August 27, 2023

by Jonathan Hodson-Walker | Aug 31, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Cellares: The company raised $255 million through a combination of debt, Series C and Series C1 venture funding in a deal led by Koch Disruptive Technologies on August 23, 2023, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending August 20, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending August 20, 2023

by Jonathan Hodson-Walker | Aug 24, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions ADARx Pharmaceuticals: The company raised $200 million of Series C venture funding in a deal led by Bain Capital Life Sciences and TCG Crossover Management on August 9, 2023, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending August 6, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending August 6, 2023

by Jonathan Hodson-Walker | Aug 11, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions CG Oncology: The company raised $105 million of Series F venture funding in a deal led by Foresite Capital Management and TCG Crossover Management on August 2, 2023, putting the company’s...
Healthcare Private Placement and M&A Transactions Review Week Ending July 31, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending July 31, 2023

by Jonathan Hodson-Walker | Aug 3, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Lumicell: The company raised $75.8 million in Series D venture funding from LaunchCapital, Rivas Capital and Burch Creative Capital on July 26, 2023, putting the company’s pre-money...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives